acetylcysteine and Pseudomonas Infections

acetylcysteine has been researched along with Pseudomonas Infections in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19904 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (10.00)29.6817
2010's10 (50.00)24.3611
2020's4 (20.00)2.80

Authors

AuthorsStudies
Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA1
Cho, SI; Jo, ER; Jun, Y; Youn, CK1
Bandyopadhaya, A; Rahme, LG; Tzika, AA1
Elgaher, WAM; Haupenthal, J; Hirsch, AKH; Lababidi, N; Ofosu Kissi, E; Rades, T; Schneider, M; Schwarz, BC; Sigal, V1
Ahamed, AI; Kim, J; Li, X; Martins-Green, M; Wang, Y; Wu, J1
de Souza Carvalho-Wodarz, C; Lababidi, N; Lehr, CM; Montefusco-Pereira, CV; Schneider, M1
Grisoli, P; Guerini, M; Pane, C; Perugini, P1
Deng, XY; Huang, SH; Li, YH; Liu, CF; Peng, L; Xiao, Y; Yang, SJ; Zeng, LT; Zhang, TS1
Cai, HR; Li, H; Luo, YF; Wang, YS; Xiao, YL; Xie, CM; Yang, Q1
Huang, X; Li, D; Wu, M; Wu, Y; Zhu, M1
Ciofu, O; Høiby, N; Jensen, PØ; Johansen, HK; Kræmer, D; Lykkesfeldt, J; Poulsen, HE; Pressler, T; Qvist, T; Skov, M1
Li, HP; Qu, JM; Xu, JF1
Bhattacharya, K; Khatua, B; Mandal, C1
De Vecchi, E; Drago, L; Mattina, R; Romanò, CL1
REAS, HW1
Chen, XH; He, LX; Li, HP; Li, ZZ; Pan, J; Qu, JM; Xu, JF; Zhang, J1
Alvim, IM; Assis, MC; Pereira, GM; Plotkowski, MC; Valente, E1
Ellison, A; Poirier, R1
Koch, C; Stafanger, G1
O'Neill, EF; Ramirez, J1

Trials

2 trial(s) available for acetylcysteine and Pseudomonas Infections

ArticleYear
The effect of short-term, high-dose oral N-acetylcysteine treatment on oxidative stress markers in cystic fibrosis patients with chronic P. aeruginosa infection -- a pilot study.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2015, Volume: 14, Issue:2

    Topics: Acetylcysteine; Administration, Oral; Adult; Antioxidants; Ascorbic Acid; Chronic Disease; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Forced Expiratory Volume; Humans; Inflammation; Lung; Male; Middle Aged; Oxidative Stress; Pseudomonas Infections; Reactive Oxygen Species; Treatment Outcome

2015
N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility.
    The European respiratory journal, 1989, Volume: 2, Issue:3

    Topics: Acetylcysteine; Adolescent; Adult; Child; Cilia; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Female; Humans; Male; Pseudomonas Infections; Respiration; Respiratory Function Tests; Time Factors

1989

Other Studies

18 other study(ies) available for acetylcysteine and Pseudomonas Infections

ArticleYear
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds

2015
In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
    International journal of pediatric otorhinolaryngology, 2019, Volume: 126

    Topics: Acetylcysteine; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microscopy, Electrochemical, Scanning; Middle Ear Ventilation; Prostheses and Implants; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Staphylococcal Infections

2019
Pseudomonas aeruginosa Quorum Sensing Molecule Alters Skeletal Muscle Protein Homeostasis by Perturbing the Antioxidant Defense System.
    mBio, 2019, 10-01, Volume: 10, Issue:5

    Topics: Acetylcysteine; Animals; Antioxidants; Cells, Cultured; Male; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; NADP; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Reactive Oxygen Species; Transcription Factors; Uncoupling Protein 3; Xanthine Oxidase

2019
Spray-drying of inhalable, multifunctional formulations for the treatment of biofilms formed in cystic fibrosis.
    Journal of controlled release : official journal of the Controlled Release Society, 2019, 11-28, Volume: 314

    Topics: Acetylcysteine; Administration, Inhalation; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Cystic Fibrosis; Drug Stability; Drug Storage; Expectorants; Horses; Mucus; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin

2019
    Journal of diabetes research, 2020, Volume: 2020

    Topics: Acetylcysteine; Animals; Biofilms; Chronic Disease; Diabetes Mellitus; Disease Models, Animal; DNA, Bacterial; Extracellular Polymeric Substance Matrix; Free Radical Scavengers; Hydrogen-Ion Concentration; In Vitro Techniques; Mice; Mice, Obese; Microbial Viability; Microscopy, Confocal; Microscopy, Fluorescence; Oxidative Stress; Protein Biosynthesis; Pseudomonas aeruginosa; Pseudomonas Infections; Wound Infection; Wounds and Injuries

2020
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2020, Volume: 157

    Topics: Acetylcysteine; Administration, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Ciprofloxacin; Curcumin; Cytokines; Drug Carriers; Drug Combinations; Drug Compounding; Expectorants; Freeze Drying; Humans; Inflammation Mediators; Macrophages; Microbial Viability; Mucus; Nanoparticles; Permeability; Polylactic Acid-Polyglycolic Acid Copolymer; Pseudomonas aeruginosa; Pseudomonas Infections; THP-1 Cells; Tobramycin

2020
Microstructured Lipid Carriers (MLC) Based on N-Acetylcysteine and Chitosan Preventing
    International journal of molecular sciences, 2021, Jan-17, Volume: 22, Issue:2

    Topics: Acetylcysteine; Anti-Infective Agents; Biofilms; Chitosan; Drug Delivery Systems; Drug Liberation; Lipids; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections

2021
Memantine Promotes Bactericidal Effect of Neutrophils Against Infection with
    Microbial drug resistance (Larchmont, N.Y.), 2022, Volume: 28, Issue:1

    Topics: Acetylcysteine; Amikacin; Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Memantine; Neutrophils; Phosphoproteins; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2022
Using ROS as a Second Messenger, NADPH Oxidase 2 Mediates Macrophage Senescence via Interaction with NF-
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Acetylcysteine; Animals; Cellular Senescence; Humans; Interleukin-6; Macrophages; NADPH Oxidase 2; NF-kappa B; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Tumor Necrosis Factor-alpha

2018
TREM-2 promotes macrophage-mediated eradication of Pseudomonas aeruginosa via a PI3K/Akt pathway.
    Scandinavian journal of immunology, 2014, Volume: 79, Issue:3

    Topics: Acetylcysteine; Androstadienes; Animals; Bacterial Load; Cell Line; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; Macrophages; Membrane Glycoproteins; Mice; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Phagocytosis; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Receptors, Immunologic; RNA Interference; RNA, Small Interfering; Signal Transduction; Wortmannin

2014
N-Acetylcysteine modulates acute lung injury induced by Pseudomonas aeruginosa in rats.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:5

    Topics: Acetylcysteine; Acute Lung Injury; Animals; Bacterial Load; Bronchoalveolar Lavage Fluid; Cell Membrane Permeability; Drug Evaluation, Preclinical; Expectorants; Lung; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley

2011
Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9.
    Journal of leukocyte biology, 2012, Volume: 91, Issue:4

    Topics: Acetylcysteine; Adult; Animals; Antigens, CD; Cell Line; CHO Cells; Cricetinae; Cricetulus; Female; Free Radical Scavengers; Glycine; Humans; Immune Evasion; Immunity, Innate; Lectins; Leukosialin; Male; Neutrophils; Phagocytosis; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Serine Proteinase Inhibitors; Sialic Acid Binding Immunoglobulin-like Lectins; Sulfonamides

2012
Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.
    The International journal of artificial organs, 2013, Volume: 36, Issue:1

    Topics: Acetylcysteine; Anti-Bacterial Agents; Arthroplasty, Replacement; Bacterial Load; Biofilms; Joint Prosthesis; Microbial Sensitivity Tests; Microscopy, Confocal; Polyethylene; Prosthesis Design; Prosthesis-Related Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Spectrophotometry; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Titanium

2013
THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS.
    The Journal of pediatrics, 1964, Volume: 65

    Topics: Acetylcysteine; Adolescent; Child; Cysteine; Cystic Fibrosis; Humans; Infant; Klebsiella; Lung Diseases; Pneumonia; Proteus Infections; Pseudomonas Infections; Pulmonary Emphysema; Radiography, Thoracic; Respiratory Function Tests; Respiratory Therapy; Spirometry; Staphylococcal Infections

1964
[The effect of antioxidant treatment in pneumonia of granulocytopenic rats].
    Zhonghua nei ke za zhi, 2004, Volume: 43, Issue:11

    Topics: Acetylcysteine; Agranulocytosis; Animals; Antioxidants; Disease Models, Animal; Male; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley

2004
Pseudomonas aeruginosa induces apoptosis in human endothelial cells.
    Microbial pathogenesis, 2000, Volume: 29, Issue:6

    Topics: Acetylcysteine; Antioxidants; Apoptosis; Catalase; Cell Line; DNA, Bacterial; Electrophoresis, Agar Gel; Endothelium; Flow Cytometry; Fluorescent Dyes; Formazans; Guanidines; Humans; Lipopolysaccharides; Microscopy, Electron; Microscopy, Fluorescence; Phenanthridines; Pseudomonas aeruginosa; Pseudomonas Infections; Reactive Oxygen Species; Tetrazolium Salts; Vitamin E

2000
Therapeutic effects of heparin on Pseudomonas-induced corneal ulceration.
    American journal of ophthalmology, 1976, Volume: 82, Issue:4

    Topics: Acetylcysteine; Administration, Topical; Adult; Animals; Colistin; Corneal Ulcer; Drug Therapy, Combination; Edetic Acid; Gentamicins; Heparin; Humans; Male; Middle Aged; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits

1976
Endobronchial Polymyxin B: experimental observations in chronic bronchitis.
    Chest, 1970, Volume: 58, Issue:4

    Topics: Acetylcysteine; Animals; Bronchitis; Candida; Catheterization; Chronic Disease; Haemophilus Infections; Humans; Male; Middle Aged; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sputum

1970